NCT02182362View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of BI 201335 NA in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

February 29, 2008

Conditions
Healthy
Interventions
DRUG

BI 201335 NA

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY